Oseltamivir GH Oseltamivir (as phosphate) 45 mg capsule blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

oseltamivir phosphate, Quantity: 59.114 mg

Disponível em:

Lupin Australia Pty Limited

Forma farmacêutica:

Capsule, hard

Composição:

Excipient Ingredients: ethanol absolute; croscarmellose sodium; pregelatinised maize starch; purified talc; povidone; sodium stearylfumarate; titanium dioxide; purified water; Gelatin; iron oxide black

Via de administração:

Oral

Unidades em pacote:

10's

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Oseltamivir is indicated for the treatment of infections due to influenza A and B viruses in adults and children including full-term neonates. Treatment should commence as soon as possible, but no later than 48 hours after the onset of the initial symptoms of infection.,Oseltamivir is indicated for the prevention of influenza in adults and children aged 1 year and older. Vaccination is the preferred method of routine prophylaxis against infection with influenza virus.

Resumo do produto:

Visual Identification: Size 4 capsule with grey opaque cap and body imprinted with 45 mg on cap and LU on body in blue ink containing white to off-white granular powder.; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status de autorização:

Registered

Data de autorização:

2020-12-03